Emily Anderson
About Emily Anderson
Emily Anderson is a Cell Therapy Specialist II in Clinical Neoantigen at Kite Pharma, where she has worked since 2019. She previously served as a Scientist at Eurofins Lancaster Laboratories from 2015 to 2018 and holds a Bachelor of Science in Biology from Penn State University.
Work at Kite Pharma
Emily Anderson has been employed at Kite Pharma since 2018. She initially held the position of Cell Therapy Specialist in Santa Monica, CA, where she contributed to various projects related to cell therapy. In 2019, she advanced to the role of Cell Therapy Specialist II, focusing on Clinical Neoantigen in Gaithersburg, MD. Her work involves the development and implementation of innovative therapies aimed at treating cancer through advanced cell therapy techniques.
Previous Experience at Eurofins Lancaster Laboratories
Before joining Kite Pharma, Emily Anderson worked as a Scientist at Eurofins Lancaster Laboratories from 2015 to 2018. During her tenure in Lancaster, Pennsylvania, she engaged in research and development activities that supported laboratory testing and analysis. This role provided her with foundational experience in scientific methodologies and laboratory practices.
Education and Expertise
Emily Anderson earned her Bachelor of Science (B.S.) degree in Biology from Penn State University, where she studied from 2011 to 2015. This educational background equipped her with a solid understanding of biological sciences, which she applies in her current role in cell therapy. Her expertise lies in the clinical application of neoantigens and their role in cancer treatment.
Professional Development
Throughout her career, Emily Anderson has focused on advancing her knowledge and skills in cell therapy and clinical research. Her roles at both Kite Pharma and Eurofins Lancaster Laboratories have allowed her to develop a strong foundation in scientific research, contributing to her professional growth in the biotechnology field.